World-first as NHS pilots new genetic testing study
January 20, 2022
A new study aimed at identifying important risk factors for many common diseases has been launched this week.
The NHS-backed HEART study (Healthcare Evaluation of Absolute Risk Testing) will focus primarily on using genetic information to augment cardiovascular disease (CVD) risk assessment.
However, it is hoped the initiative will pave the way for the use of a single blood sample to calculate the risk of numerous common diseases simultaneously, including diabetes, osteoporosis, and common cancers like breast and bowel cancer.
The testing could also prove invaluable in accelerating treatment pathways and optimisation of vital NHS resources by identifying patients who will benefit from preventative measures, such as lifestyle changes and extra screening.
The HEART study is currently ongoing in ten GP practices in the North of England and full results are expected to be published later this year.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.